GOOD
BUSINESS
Government disburses ₹35,354 crore under PLI schemes till March 2026

The pharmaceuticals sector recorded cumulative sales of over ₹3.64 lakh crore under the PLI scheme, enabling the domestic manufacture of 1,931 products, including 191 bulk drugs produced in India for the first time
Read the original at The Hindu BusinessLine ↗